# clm_5EB4A92B130D

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 3,271,000,000 United States dollar  
valid_from: 2021-06-30  
valid_to: 2021-09-30  
published: 2021-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0FC04F2EC1D4  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 3,271,000,000 United States dollar", as of 2021-06-30 (until 2021-09-30). Claim clm_5EB4A92B130D, https://asof.is/claim/clm_5EB4A92B130D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2021, filed 2021-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427221000186/0000014272-21-000186-index.htm (primary, SEC EDGAR 10-Q Q2 FY2021, published 2021-07-28)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,225,000,000 United States dollar | valid 2021-03-31 to 2021-06-30 | conf 0.95 | superseded | superseded_by [clm_5EB4A92B130D](/claim/clm_5EB4A92B130D.md) | [clm_A28CB9F163E6](/claim/clm_A28CB9F163E6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.